Brought to you by:

Cell & Gene Therapy

pause button on blue background
Biotech

UniQure halts mid- to high-dosing for AAV gene therapy

Two patients receiving uniQure’s gene therapy at a mid-level dose have experienced asymptomatic Grade 3 liver enzyme elevations.
Spiral helical welded steel pipe

Lilly drops 3 clinical programs, including Prevail gene therapy

Feb 4, 2026 12:33pm
Charles River Boston Massachusetts

Charles River to close Maryland CDMO site, lay off 20 staffers

Feb 3, 2026 12:20pm
Vinay Prasad

FDA to ‘carefully shepherd’ CAR-T for autoimmune disease: Prasad

Feb 3, 2026 11:40am
layoffs employees crossed off
Favicon Fierce Pharma

Thermo Fisher winds down Boston area plant

Feb 2, 2026 12:22pm
China Chinese Flag draped over gold bars economy stock market finance

AstraZeneca vows $15B China investment to boost R&D capabilities

Jan 29, 2026 5:50am